Pharmacovigilance Data & Signal Analysis
Comprehensive signal detection and regulatory communication. We synthesize complex safety data into clear, high-level reports and evidence-based guidance for decision-makers.
Actionable insights, clear reporting
Our commitment goes beyond analysis. We provide guidance that helps organizations act, whether improving risk management, informing regulatory submissions, or optimizing clinical strategies.
What we do
- Adverse event signal detection and trend analysis
- Risk-benefit assessment and safety profiling of medicinal products
- Aggregate report generation (PSURs, DSURs) and regulatory submission support
- Evaluation of risk minimization measures and pharmacovigilance systems
- Data integration and analysis from spontaneous reports ( such as FAERS), EHR, and clinical trials
Our approach
- Statistical analysis using R, SAS, or similar tools for safety data
- Integration of multi-source data such as VigiBase, FAERS, and clinical trial results
- Application of pharmacovigilance methods grounded in real-world practice
- Clear communication of safety findings for both technical and non-technical audiences
Outcomes we deliver
- Identification of emerging safety signals and trends for proactive risk management
- Evidence to support regulatory submissions, labeling changes, and product defense
- Clear, defensible insights for aggregate reports, publications, and leadership briefings
- Enhanced patient safety and optimized benefit-risk profiles for pharmaceutical products